Table 4. Total risk score and the predicted 2–5-year risk of hepatocellular carcinoma in the development group (n = 883).
Risk scores | Year 2 | Year 3 | Year 4 | Year 5 |
---|---|---|---|---|
0 | 0.5% | 0.8% | 1.8% | 2.4% |
1 | 0.8% | 1.2% | 2.5% | 3.5% |
2 | 1.1% | 1.7% | 3.6% | 4.9% |
3 | 1.5% | 2.4% | 5.1% | 6.9% |
4 | 2.2% | 3.4% | 7.1% | 9.7% |
5 | 3.1% | 4.7% | 10.0% | 13.4% |
6 | 4.3% | 6.7% | 13.9% | 18.6% |
7 | 6.1% | 9.3% | 19.1% | 25.3% |
8 | 8.6% | 13.0% | 26.1% | 34.0% |
9 | 12.0% | 18.0% | 34.9% | 44.6% |
10 | 16.6% | 24.6% | 45.7% | 56.9% |
11 | 22.8% | 33.1% | 58.1% | 69.8% |
12 | 30.8% | 43.5% | 70.9% | 81.8% |
13 | 40.8% | 55.6% | 82.8% | 91.1% |
14 | 52.5% | 68.5% | 91.8% | 96.8% |
15 | 65.3% | 80.7% | 97.1% | 99.3% |